CBL and myeloid sarcoma: The dichotomy we observed between high CSF Cbl levels and low SC Cbl levels supports the notion that a “therapeutic” Cbl administration during the MS course seems to be useless, because of an apparently reduced permeability of the blood–spinal cord barrier to Cbl.